Spatially informed Bayesian neural network for neurodegenerative diseases classification
![Thumbnail](/xmlui/bitstream/handle/10234/201890/83938.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Impact
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/7037
comunitat-uji-handle3:10234/8635
comunitat-uji-handle4:
INVESTIGACIONMetadata
Title
Spatially informed Bayesian neural network for neurodegenerative diseases classificationDate
2022Publisher
WileyISSN
0277-6715; 1097-0258Bibliographic citation
PAYARES‐GARCIA, David; MATEU, Jorge; SCHICK, Wiebke. Spatially informed Bayesian neural network for neurodegenerative diseases classification. Statistics in medicine, 2023, vol. 42, núm. 2, p. 105-121Type
info:eu-repo/semantics/articlePublisher version
https://onlinelibrary.wiley.com/doi/full/10.1002/sim.9604Version
info:eu-repo/semantics/publishedVersionSubject
Abstract
Magnetic resonance imaging (MRI) plays an increasingly important role in the diagnosis and prognosis of neurodegenerative diseases. One field of extensive clinical use of MRI is the accurate and automated classification ... [+]
Magnetic resonance imaging (MRI) plays an increasingly important role in the diagnosis and prognosis of neurodegenerative diseases. One field of extensive clinical use of MRI is the accurate and automated classification of degenerative disorders. Most of current classification studies either do not mirror medical practice where patients may exhibit early stages of the disease, comorbidities, or atypical variants, or they are not able to produce probabilistic predictions nor account for uncertainty. Also, the spatial heterogeneity of the brain alterations caused by neurodegenerative processes is not usually considered, despite the spatial configuration of the neuronal loss is a characteristic hallmark for each disorder. In this article, we propose a classification technique that incorporates uncertainty and spatial information for distinguishing between healthy subjects and patients from four distinct neurodegenerative diseases: Alzheimer's disease, mild cognitive impairment, Parkinson's disease, and Multiple Sclerosis. We introduce a spatially informed Bayesian neural network (SBNN) that combines a three-dimensional neural network to extract neurodegeneration features from MRI, Bayesian inference to account for uncertainty in diagnosis, and a spatially informed MRI image using hidden Markov random fields to encode cerebral spatial information. The SBNN model demonstrates that classification accuracy increases up to 25% by including a spatially informed MRI scan. Furthermore, the SBNN provides a robust probabilistic diagnosis that resembles clinical decision-making and can account for the heterogeneous medical presentations of neurodegenerative disorders. [-]
Is part of
Statistics in medicine, 2023, vol. 42, núm. 2, p. 105-121Funder Name
National Institutes of Health | U.S. Department of Defense
Project code
U01 AG024904 | W81XWH‐12‐2‐0012
Rights
info:eu-repo/semantics/openAccess
This item appears in the folowing collection(s)
- MAT_Articles [766]
Except where otherwise noted, this item's license is described as This is an open access article under the terms of theCreative Commons AttributionLicense, which permits use, distribution and reproduction in any medium, provided theoriginal work is properly cited.© 2022 The Authors.Statistics in Medicinepublished by John Wiley & Sons Ltd.